Company profile for Belief BioMed

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Founded in 2018, Belief BioMed is aiming to become a globally leading gene therapy company by providing innovative gene therapies with improved efficacy and safety for monogenic disorder diseases, age-related degenerative diseases, and certain malignant diseases through its AAV vector technology from early discovery to commercialization. The R&D and production strengths of Belief BioMed have been recognized by top investment i...
Founded in 2018, Belief BioMed is aiming to become a globally leading gene therapy company by providing innovative gene therapies with improved efficacy and safety for monogenic disorder diseases, age-related degenerative diseases, and certain malignant diseases through its AAV vector technology from early discovery to commercialization. The R&D and production strengths of Belief BioMed have been recognized by top investment institutions and pharmaceutical enterprises.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
China
Address
Address
Building 4, 389 Jinglian Road, Minhang District, Shanghai
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/belief-biomed-and-takeda-china-jointly-announced-bbm-h901-dalnacogene-ponparvovec-injection-chinas-first-hemophilia-b-gene-therapy-was-officially-approved-302425572.html

PR NEWSWIRE
10 Apr 2025

https://www.prnewswire.com/news-releases/belief-biomed-to-collaborate-with-askbio-to-explore-the-potential-of-new-gene-therapies-302258260.html

PR NEWSWIRE
25 Sep 2024

https://www.prnewswire.com/news-releases/belief-biomed-successfully-completed-dosing-of-first-subject-in-the-registrational-clinical-trial-for-hemophilia-a-302025238.html

PR NEWSWIRE
03 Jan 2024

https://www.prnewswire.com/news-releases/belief-biomed-announces-a-key-milestone-of-dosing-completion-for-all-subjects-in-its-registrational-clinical-trial-of-bbm-h901-301804990.html

PR NEWSWIRE
23 Apr 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty